These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 30189811)

  • 1. Binary and ternary complexes of norfloxacin to improve the solubility of the active pharmaceutical ingredient.
    Ponce-Ponte M; Aloisio C; Romero-Guerra DM; Gracia-Vásquez S; Garnero C; Longhi M
    Ther Deliv; 2018 Sep; 9(9):639-652. PubMed ID: 30189811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of β-cyclodextrin on the Properties of Norfloxacin Form A.
    Chierentin L; Garnero C; Chattah AK; Delvadia P; Karnes T; Longhi MR; Salgado HR
    AAPS PharmSciTech; 2015 Jun; 16(3):683-91. PubMed ID: 25511811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and comparison of binary and ternary inclusion complexes of aripiprazole using L-arginine/lysine and MβCD/HPβCD by using different molar ratios.
    Awais S; Afridi M; Batool A; Ansari MT; Sultana K; Momal H; Alsanie WF; S Alamri A; Alhomrani M
    Pak J Pharm Sci; 2024 Jan; 37(1(Special)):245-255. PubMed ID: 38747276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicochemical characterization of efavirenz-cyclodextrin inclusion complexes.
    Sathigari S; Chadha G; Lee YH; Wright N; Parsons DL; Rangari VK; Fasina O; Babu RJ
    AAPS PharmSciTech; 2009; 10(1):81-7. PubMed ID: 19148759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diloxanide furoate binary complexes with β-, methyl-β-, and hydroxypropyl-β-cyclodextrins: inclusion mode, characterization in solution and in solid state and in vitro dissolution studies.
    Aloisio C; Longhi M
    Pharm Dev Technol; 2018 Sep; 23(7):723-731. PubMed ID: 28758845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of polyvinylpyrrolidone on naproxen complexation with hydroxypropyl-beta-cyclodextrin.
    Mura P; Faucci MT; Bettinetti GP
    Eur J Pharm Sci; 2001 May; 13(2):187-94. PubMed ID: 11297903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailability enhancement of poorly water soluble and weakly acidic new chemical entity with 2-hydroxy propyl-beta-cyclodextrin: selection of meglumine, a polyhydroxy base, as a novel ternary component.
    Basavaraj S; Sihorkar V; Shantha Kumar TR; Sundaramurthi P; Srinivas NR; Venkatesh P; Ramesh M; Kumar Singh S
    Pharm Dev Technol; 2006; 11(4):443-51. PubMed ID: 17101515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced Solubility and Stability of Aripiprazole in Binary and Ternary Inclusion Complexes Using Hydroxy Propyl Beta Cyclodextrin (HPβCD) and L-Arginine.
    Awais S; Farooq N; Muhammad SA; El-Serehy HA; Ishtiaq F; Afridi M; Ahsan H; Ullah A; Nadeem T; Sultana K
    Molecules; 2023 May; 28(9):. PubMed ID: 37175270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved Aqueous Solubility and Antihypercholesterolemic Activity of Ezetimibe on Formulating with Hydroxypropyl-β-Cyclodextrin and Hydrophilic Auxiliary Substances.
    Srivalli KM; Mishra B
    AAPS PharmSciTech; 2016 Apr; 17(2):272-83. PubMed ID: 26077622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving the Stability and the Pharmaceutical Properties of Norfloxacin Form C Through Binary Complexes with β-Cyclodextrin.
    Garnero C; Chattah AK; Aloisio C; Fabietti L; Longhi M
    AAPS PharmSciTech; 2018 Jul; 19(5):2255-2263. PubMed ID: 29748896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of curcumin-hydroxypropyl-β-cyclodextrin inclusion complex by cosolvency-lyophilization procedure to enhance oral bioavailability of the drug.
    Li N; Wang N; Wu T; Qiu C; Wang X; Jiang S; Zhang Z; Liu T; Wei C; Wang T
    Drug Dev Ind Pharm; 2018 Dec; 44(12):1966-1974. PubMed ID: 30059244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inclusion Complexation of Etodolac with Hydroxypropyl-beta-cyclodextrin and Auxiliary Agents: Formulation Characterization and Molecular Modeling Studies.
    Sherje AP; Kulkarni V; Murahari M; Nayak UY; Bhat P; Suvarna V; Dravyakar B
    Mol Pharm; 2017 Apr; 14(4):1231-1242. PubMed ID: 28248111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binary inclusion complexes of diflunisal with β-cyclodextrin and hydroxypropyl-β-cyclodextrin: Preparation and characterization.
    Bashir M; Syed HK; Asghar S; Irfan M; Aslam N; Iqbal MS; Khan IU; Shah PA; Khan NR; Ahmad J; Saleem M; Asif M
    Pak J Pharm Sci; 2020 Sep; 33(5(Supplementary)):2307-2315. PubMed ID: 33832905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of chitosan on progesterone release from hydroxypropyl-beta-cyclodextrin complexes.
    Cerchiara T; Luppi B; Bigucci F; Zecchi V
    Int J Pharm; 2003 Jun; 258(1-2):209-15. PubMed ID: 12753767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solubility and release modulation effect of sulfamerazine ternary complexes with cyclodextrins and meglumine.
    Aloisio C; de Oliveira AG; Longhi M
    J Pharm Biomed Anal; 2014 Nov; 100():64-73. PubMed ID: 25129645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug/cyclodextrin solid systems in the design of hydrophilic matrices: a strategy to modulate drug delivery rate.
    Miro A; Quaglia F; Giannini L; Cappello B; La Rotonda MI
    Curr Drug Deliv; 2006 Oct; 3(4):373-8. PubMed ID: 17076639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β-cyclodextrin complexation as an approach to enhance the biopharmaceutical properties of Norfloxacin B Hydrate.
    Bueno MS; Chierentin L; Bongioanni A; Nunes Salgado HR; Longhi MR; Garnero C
    Carbohydr Res; 2019 Nov; 485():107818. PubMed ID: 31542588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of ternary complexes of meloxicam-HPbetaCD and PVP or L-arginine prepared by the spray-drying technique.
    El-Maradny HA; Mortada SA; Kamel OA; Hikal AH
    Acta Pharm; 2008 Dec; 58(4):455-66. PubMed ID: 19103579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of β-cyclodextrin-norfloxacin inclusion complexes. Part 1. Preparation, physicochemical and microbiological characterization.
    Mendes C; Wiemes BP; Buttchevitz A; Christ AP; Ribas KG; Adams AI; Silva MA; Oliveira PR
    Expert Rev Anti Infect Ther; 2015 Jan; 13(1):119-29. PubMed ID: 25488142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.